- Home
- NSYS vs ENLV Comparison
NSYS vs ENLV Comparison
Compare NSYS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSYS
- ENLV
- Stock Information
- Founded
- NSYS 1981
- ENLV 2005
- Country
- NSYS United States
- ENLV Israel
- Employees
- NSYS N/A
- ENLV N/A
- Industry
- NSYS Industrial Machinery/Components
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- NSYS Technology
- ENLV Health Care
- Exchange
- NSYS Nasdaq
- ENLV Nasdaq
- Market Cap
- NSYS 25.4M
- ENLV 23.7M
- IPO Year
- NSYS N/A
- ENLV 1995
- Fundamental
- Price
- NSYS $8.93
- ENLV $0.97
- Analyst Decision
- NSYS
- ENLV Strong Buy
- Analyst Count
- NSYS 0
- ENLV 2
- Target Price
- NSYS N/A
- ENLV $10.00
- AVG Volume (30 Days)
- NSYS 7.1K
- ENLV 46.3K
- Earning Date
- NSYS 05-14-2025
- ENLV 05-30-2025
- Dividend Yield
- NSYS N/A
- ENLV N/A
- EPS Growth
- NSYS N/A
- ENLV N/A
- EPS
- NSYS N/A
- ENLV N/A
- Revenue
- NSYS $120,813,000.00
- ENLV N/A
- Revenue This Year
- NSYS N/A
- ENLV N/A
- Revenue Next Year
- NSYS N/A
- ENLV N/A
- P/E Ratio
- NSYS N/A
- ENLV N/A
- Revenue Growth
- NSYS N/A
- ENLV N/A
- 52 Week Low
- NSYS $7.25
- ENLV $0.81
- 52 Week High
- NSYS $15.55
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- NSYS 49.64
- ENLV 49.07
- Support Level
- NSYS $8.22
- ENLV $0.93
- Resistance Level
- NSYS $10.79
- ENLV $0.98
- Average True Range (ATR)
- NSYS 0.50
- ENLV 0.05
- MACD
- NSYS -0.01
- ENLV -0.00
- Stochastic Oscillator
- NSYS 27.75
- ENLV 43.09
About NSYS Nortech Systems Incorporated
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.